Measurement of urinary chemokine and growth factor messenger RNAs: A noninvasive monitoring in lupus nephritis
- 1 February 2006
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 69 (4), 747-753
- https://doi.org/10.1038/sj.ki.5000132
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Urine Chemokines as Biomarkers of Human Systemic Lupus Erythematosus ActivityJournal of the American Society of Nephrology, 2005
- Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosusThe Journal of Pathology, 2005
- Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritisArthritis & Rheumatism, 2004
- Transforming Growth Factor-β1 Induces Vascular Endothelial Growth Factor Expression in Murine Proximal Tubular Epithelial CellsNephron Experimental Nephrology, 2003
- Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritisArthritis & Rheumatism, 2003
- Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamideArthritis & Rheumatism, 2002
- Noninvasive Diagnosis of Renal-Allograft Rejection by Measurement of Messenger RNA for Perforin and Granzyme B in UrineNew England Journal of Medicine, 2001
- Clinical and prognostic value of serial renal biopsies in lupus nephritisAmerican Journal of Kidney Diseases, 1999
- TGF-β and the endothelium during immune injuryKidney International, 1997
- Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcomeKidney International, 1984